Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.22.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CH.1.1.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.109NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JE.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JH.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.1.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FW.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JS.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.2.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HG.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GE.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCQNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JC.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.41.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.3.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.108NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.104NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HH.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.1.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.4.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GW.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.2 (Zeta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.499NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.212NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.61NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used